#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous lupus erythematosus Hereditary angioedema Oropharyngeal squamous cell carcinoma Asthma Craniopharyngioma Gastrooesophageal cancer Polymyositis Chordoma Neutropenia Castleman's disease Drug eruption Congenital pseudarthrosis Synovial sarcoma metastatic Glycogen storage disease type V Gastroenteropancreatic neuroendocrine tumour disease More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome – Trials in Disease Leiomyosarcoma recurrent – Diagnostics Mantle cell lymphoma refractory – Basic Information Alagille syndrome – Trials in Disease Ewing’s sarcoma – Basic Information Noonan syndrome – Diagnostics Sjogren’s syndrome – Diagnostics IgA nephropathy – Basic Information Mantle cell lymphoma stage IV – Life with Disease Synovial sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000034798 Clopidogrel Ketamine Hydrochloride Tpst-1120 Fosphenytoin Sodium Pralatrexate Iopromide Mianserin Hydrochloride VENT-03 Garetosmab Mifepristone Retinol Acetate Cefixime XMAB942 Tegoprubart Napabucasin Copper (64Cu) Chloride BROLUCIZUMAB Nitrous Oxide Tolinapant Lactate More therapies…

    Learn about Your Condition

    Myocardial ischaemia Thyroid cancer Biliary adenoma Neuroendocrine carcinoma Autoimmune haemolytic anaemia Endometrial cancer Aicardi-Goutieres syndrome Thyroid cancer metastatic Adenovirus infection Pain Still's disease Irritable bowel syndrome Keratosis follicular Polymyalgia rheumatica Netherton's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study of single-dose oritavancin safety and tolerability in children with acute bacterial skin and skin structure infections

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Skin bacterial infection
    Investigated Drugs:
    • Oritavancin
    • Aztreonam
    Bulgaria Greece Latvia Lithuania Poland Portugal +2

  • Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Bendamustine
    • Fludarabine
    Austria Bulgaria Czechia Denmark France Germany +7

  • Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Efgartigimod Alfa
    Bulgaria Greece Italy Norway Portugal Romania

  • Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

    Not recruiting

    2 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Lu Ag09222
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

    Not recruiting

    3 1
    Investigated Diseases:
    • Thalassaemia
    Investigated Drugs:
    • Mitapivat
    Bulgaria Denmark France Germany Greece Italy +2

  • Study on Upadacitinib for Children with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ciprofloxacin
    • Methotrexate
    • Sulfasalazine
    Belgium Bulgaria France Greece Italy Poland +1

  • Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria

  • Study on UGN-103 (Mitomycin) for Treating Low Grade Nonmuscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Poloxamer 407
    Bulgaria Estonia Latvia Romania Spain

  • Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Epcoritamab
    • Gemcitabine
    • Lenalidomide
    Belgium Bulgaria Croatia Czechia France Greece +5

  • Study of Plozasiran for Adults with Severe Hypertriglyceridemia

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia Hungary Italy +4
Previous Page
1 … 11 12 13 14 15 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!